Follow The Filings

NEOG Neogen

Neogen earnings company data as of 8:02 PM ET 10/22

  • 0 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2027 Q1 8 Oct EPS 0.05 -0.05 Miss
Rev — — —

Insider trades

Open-market buys and sales by NEOG's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NEOG insider trades
  • $14K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Mikheal Nassif CEO
    Buy
    $6,035 505 shares at $11.95 +47% to stake
    Traded Oct 9 Filed Oct 9
    ↗
  2. Mikheal Nassif CEO
    Buy
    $4,370 370 shares at $11.81 +53% to stake
    Traded Aug 4 Filed Aug 6
    ↗
  3. Mikheal Nassif CEO
    Buy
    $252 23 shares at $10.94 +3.4% to stake
    Traded Feb 17 Filed Feb 17
    ↗
  4. Mikheal Nassif CEO
    Buy
    $486 49 shares at $9.93 +7.8% to stake
    Traded Jan 26–Feb 2 Filed Feb 2
    ↗
  5. Mikheal Nassif CEO
    Buy
    $1,279 137 shares at $9.33 +28% to stake
    Traded Jan 16 Filed Jan 16
    ↗
  6. Mikheal Nassif CEO
    Buy
    $1,106 177 shares at $6.25 +56% to stake
    Traded Nov 3, 2025 Filed Nov 7, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 26 stock grants, 17 option exercises, and 10 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.